FDG-PET/CT can help determine retinoblastoma treatment plan

02/14/2012 | AuntMinnie.com (free registration)

A study published in the Journal of Nuclear Medicine found that optic nerve FDG uptake detected with PET/CT scans can be associated with lower event-free and overall survival in pediatric patients with stage III retinoblastoma. Based on second PET/CT results, the researchers also found that event-free and overall survival for patients with complete and partial response to therapy was 62% and 69%, respectively, compared with 0% for patients who did not respond to therapy. The study shows that FDG-PET/CT imaging can aid in determining the right treatment for patients, the researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY